Another biomarker identified within our study to be elevated in severe COVID-19, but not reported before, is ALCAM (Activated Leukocyte Cell Adhesion Molecule, CD166), which plays a role in transmigration of monocytes across pulmonary endothelium and in T-cell activation38. The gene discussed is ALCAM; the disease is COVID-19.